Nevertheless, our evidence now indicates that USP6 and PARP-1 should be considered important factors in the responsiveness of cancer cells to radiation therapy, particularly proton beam therapy that can generate high-LET protons and CDD at the distal end of the Bragg peak. This evidence concerns the gene USP6 and cancer.